Pharmaceutical Technology-02-01-2016

Sustainable harvesting combined with CMO expertise helped Centroflora CMS ensure supply continuity after it acquired Boehringer Ingelheim's non-captive API phytochemicals portfolio.

Steven Denham, director of biostatistics at MPI Research, discusses the impact the Standard for Exchange of Nonclinical Data may have on the pharmaceutical industry.

Mergers and acquisitions have changed the shape of the contract services market as big players seek to build full-service capabilities.

Transparent communications, both qualitative and quantitative data, and a clear understanding of each other’s needs are keys to collaborating on better product quality.

For successful partnerships, it’s important to take a long-term view, focus on simple designs, and address potential payer concerns up front.

Only half of new drugs make it past Phase III. Adopting best practices and collaborating more closely with contract research organizations can help ensure success.

Despite the move to more strategic partnerships, research shows that tactical outsourcing is still alive and well.

Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies.

Keith Moore, vice-president of analytical services, Metrics Contract Services discusses gains use in dissolution testing.

Click the title above to open the Pharmaceutical Technology 2016 Partnerships in Outsourcing Supplement in an interactive PDF format.